Outsourced Pharma Webinars

31. A Comprehensive Solution With Targeted And Non-Targeted Approaches 8/26/2026

    Explore how non-targeted NGS and targeted molecular assays can work together during cell line characterization to provide broad virus detection while supporting evolving regulatory expectations.

32. Selecting A Test Method For Your Container System 8/21/2026

    Selecting CCIT requires matching methods like vacuum decay to product traits. Assess liquid conductivity, headspace, and lifecycle risks to build a compliant leak-detection strategy.

33. Targeted LNPs: From Ligand Conjugation To Process Optimization 8/20/2026

    Explore an integrated workflow for targeted lipid nanoparticle development, covering ligand conjugation, candidate screening, and scalable manufacturing for cell-specific nucleic acid delivery.

34. When Unexpected Particles Threaten Your Biologic 8/13/2026

    Particle contamination risks biologic safety. Advanced tools like Raman and SEM-EDS identify root causes fast to support robust, regulator-ready strategies that protect product quality.

35. Life Cycle Assessment (LCA): Empowering Sustainable Decisions 8/7/2026

    Learn how Life Cycle Assessment converts environmental data into practical insights, helping improve product development, sustainability strategies, and decision-making.

36. Controlling Nitrosamine Risk In Drug Products: Detection, Formation, And Control Strategies 7/31/2026

    Bioprocess control relies on clear insight into cell health. Automated tracking cuts risk, saves time, boosts yield, and helps scale up fast to ensure smooth, top quality batch production runs daily.

37. Enhancing AAV Manufacturing Yield Via Mini-Helper Plasmid 7/23/2026

    Learn how rational plasmid engineering and promoter optimization can significantly improve AAV productivity while reducing plasmid burden, paving the way for more efficient and scalable viral vector manufacturing.

38. When High-Stakes ADC Decisions Can't Wait for More Material or Better Data 7/21/2026

    Learn how a material-sparing analytical workflow can generate reliable data, reduce dependence on calibration assays, and support faster, more confident candidate evaluation.

39. Beyond Outsourcing: Turning Your CDMO Into A Value-Creation Engine 7/17/2026

    Learn practical strategies to strengthen development, reduce risk, and make smarter partnership decisions that can help advance your next program with confidence.

40. Leveraging 3Rs For Superior Cell Line Characterization 7/13/2026

    Explore how non-animal methods, including next generation sequencing, are advancing biologics safety testing through the 3Rs while supporting faster adventitious virus testing and more.